Browsing Tag
Alzheimer’s treatment
5 posts
Athira Pharma completes patient dosing in Phase 2/3 trial of fosgonimeton in AD
Athira Pharma, Inc. (NASDAQ: ATHA), a prominent biopharmaceutical company specializing in neurodegenerative diseases, has announced the completion of…
July 10, 2024
FDA approves Eli Lilly’s Kisunla for Alzheimer’s treatment
The U.S. Food and Drug Administration (FDA) has approved Kisunla (donanemab-azbt), an Alzheimer’s treatment developed by Eli Lilly…
July 4, 2024
Eisai initiates rolling submission for Leqembi autoinjector BLA to FDA
BioArctic AB’s partner Eisai has initiated the rolling submission of a Biologics License Application (BLA) to the U.S.…
May 15, 2024
BioArctic and Eisai team up on Alzheimer’s disease candidate BAN2802
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) has entered into a new research evaluation agreement with Eisai Co.,…
April 21, 2024
Breakthrough Alzheimer’s treatments on the horizon: New drugs and potential vaccine
Global Health Update — Promising developments in the fight against Alzheimer’s disease could significantly alter the landscape of…
March 21, 2018